United Services Automobile Association Editas Medicine, Inc. Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$18.19 - $31.79 $447,110 - $781,398	-24,580 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$27.65 - $38.39 $111,401 - $154,673	-4,029 Reduced 14.08%	24,580 $782,000
Q2 2018 Aug 10, 2018	BUY	$31.4 - $41.01 $18,588 - $24,277	592 Added 2.11%	28,609 $1.03 Million
Q1 2018 May 14, 2018	SELL	$29.84 - $44.08 $145,708 - $215,242	-4,883 Reduced 14.84%	28,017 $929,000
Q4 2017 Feb 14, 2018	SELL	$21.89 - $31.34 $993,806 - $1.42 Million	-45,400 Reduced 57.98%	32,900 $1.01 Million
Q3 2017 Nov 14, 2017	BUY	$15.81 - $24.01 $1.24 Million - $1.88 Million	78,300	78,300 $1.88 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.